Evidence map›Paper›PMID 37196646›Full record

ArticleBlood advances2023

Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.

Kattria van der Ploeg, Rosa Sottile, Theodota Kontopoulos, Brian C Shaffer, Genovefa A Papanicolaou, Molly A Maloy, Christina Cho, Kevin S Robinson, Miguel-Angel Perales, Jean-Benoît Le Luduec and 1 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Loss of circulating CD8αbioRxiv : the preprint server for biology · 2024
    Article
  12. Single-cell profiling aligns CD56Frontiers in immunology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Kattria van der PloegHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-3183-3190
Rosa SottileHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0003-2950-9508
Theodota KontopoulosHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0003-2054-4112
Brian C ShafferDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Genovefa A PapanicolaouDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-2891-079X
Molly A MaloyDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0001-9831-3416
Christina ChoDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-7964-3011
Kevin S RobinsonDepartment of Medicine, Weill Cornell Medical College, New York, NY.ORCID 0000-0001-7558-4002
Miguel-Angel PeralesDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-5910-4571
Jean-Benoît Le LuduecHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-1046-2941
Katharine C HsuHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0003-2827-5324
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
T LYMPHOCYTE SUBSET FUNCTION POST-TRANSPLANTATIONP01CA023766 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SCHEINBERG, DAVID A · 1985 to 2023
$59.0M
KIR and HLA in cis and trans cooperatively shape human NK educationR01AI125651 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI HSU, KATHARINE C · 2016 to 2020
$2.2M
NCI NIH HHS P01 CA023766NCI NIH HHS P30 CA008748NIAID NIH HHS R01 AI125651
6 · The paper itself

Abstract

Cytomegalovirus (CMV) infection is associated with the expansion of a mature NKG2C+FcεR1γ- natural killer (NK) cell population. The exact mechanism underlying the emergence of NKG2C+ NK cells, however, remains unknown. Allogeneic hematopoietic cell transplantation (HCT) provides an opportunity to longitudinally study lymphocyte recovery in the setting of CMV reactivation, particularly in patients receiving T-cell-depleted (TCD) allografts. We analyzed peripheral blood lymphocytes from 119 patients at serial time points after infusion of their TCD allograft and compared immune recovery with that in samples obtained from recipients of T-cell-replete (T-replete) (n = 96) or double umbilical cord blood (DUCB) (n = 52) allografts. NKG2C+ NK cells were detected in 92% (45 of 49) of recipients of TCD HCT who experienced CMV reactivation. Although NKG2A+ cells were routinely identifiable early after HCT, NKG2C+ NK cells were identified only after T cells could be detected. T-cell reconstitution occurred at variable times after HCT among patients and predominantly comprised CD8+ T cells. In patients with CMV reactivation, recipients of TCD HCT expressed significantly higher frequencies of NKG2C+ and CD56neg NK cells compared with patients who received T-replete HCT or DUCB transplantation. NKG2C+ NK cells after TCD HCT were CD57+FcεR1γ+ and degranulated significantly more in response to target cells compared with the adaptive the NKG2C+CD57+FcεR1γ- NK cell population. We conclude that the presence of circulating T cells is associated with the expansion of a CMV-induced NKG2C+ NK cell population, a potentially novel example of developmental cooperation between lymphocyte populations in response to viral infection.

Indexed as

Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantationCD8-Positive T-LymphocytesCytomegalovirusHumansKiller Cells, Natural

Identifiers

PMID37196646
PMCPMC10561005
OpenAlexW4376866862

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.